Rotatory behavior induced in nigra-lesioned rats by n-propylnoraporphine, apomorphine, and levodopa (Q48457568)

11 February 2018

title

Rotatory behavior induced in nigra-lesioned rats by N-propylnoraporphine, apomorphine, and levodopa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1143000

26 August 2022

Rotatory behavior induced in nigra-lesioned rats by n-propylnoraporphine, apomorphine, and levodopa (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

13 October 2023

1 reference

1 reference

J. S. Mendez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1143000

26 August 2022

G. C. Cotzias

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1143000

26 August 2022

B. W. Finn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1143000

26 August 2022

K. Dahl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1143000

26 August 2022

language of work or name

English

0 references

publication date

1 June 1975

1 reference

11 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0024320575900594?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

https://api.elsevier.com/content/article/PII:0024320575900594?httpAccept=text/plain

13 October 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

13 October 2023

1 reference

11 February 2018

volume

16

1 reference

11 February 2018

issue

11

1 reference

11 February 2018

page(s)

1737-1742

1 reference

11 February 2018

Aromatic Amino Acids and Modification of Parkinsonism

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

Modification of Parkinsonism--chronic treatment with L-dopa

13 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

l-DOPA treatment in Parkinson's disease: Effect on dopamine and related substances in discrete brain regions

13 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

Protein Intake and Treatment of Parkinson's Disease with Levodopa

13 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

Injected apomorphine and orally administered levodopa in Parkinsonism

13 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

Aporphines. 8. Total synthesis and pharmacological evaluation of (plus or minus)-apomorphine, (plus or minus)-apocodeine, (plus or minus)-N-n-propylnorapomorphine, and (plus or minus)-N-n-propylnorapocodeine

13 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

13 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats

13 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90059-4

13 October 2023

Identifiers

1 reference

11 February 2018

1 reference

11 February 2018